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Abstract
Autophagy  is  an  evolutionarily  conserved  intracellular  recycling  pathway  that  is
indispensable for cellular quality control. Dysfunctional autophagy has been associated
with several neurodegenerative, myodegenerative, infectious, and cancerous disorders.
Autophagic processes are not only important for cellular maintenance in the retina but
also intimately involved with phagocytosis and the very core of retinal visual process.
Additionally,  excessively  upregulated  autophagy  may  culminate  into  a  cell  death
modality, which may be detrimental to the non-dividing cells of various eye segments.
Major advances have been made in understanding the role and fate of autophagy in
different ocular tissue layers. In this chapter, we summarize the current understanding
of autophagy in the eye in the context of development, aging, and disease. We also
speculate on the putative therapeutic strategies where autophagy may be incorporated
to treat oculopathies.
Keywords: retinal degeneration, RPE, photoreceptor, lens, cornea, retinal ganglion
cells, phagocytosis, lipofuscin, autophagic flux, lysosomes, non-canonical autophagy,
diurnal rhythm, circadian, cell death, aging, neovascularization, glaucoma, diabetic
retinopathy, macular degeneration
1. Introduction
As a housekeeping cellular degradative and recycling process, autophagy is indispensable
for the maintenance of ocular physiology. Since the early 2000s, research in understanding
the mechanism and role of autophagy in development and disease has received a tremendous
boost [1]. A rapidly growing wealth of data, focused on the diverse role of autophagy in
ocular development, physiology, or disease, has enabled researchers to begin understanding
this complex process with the hope of manipulating it as a therapeutic tool in treating a
myriad of disorders that often lead to loss of visual acuity or complete blindness [2, 3].
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The eye has a complex anatomy (Figure 1A), with a plethora of specialized cells working
together to create the visual perception [4]. Almost all cells in the developed eye have some
common characteristics; they have high metabolic rates; are highly differentiated and are either
post-mitotic or slowly dividing [5–10]. In addition, owing to the high blood perfusion rates,
the eye is an oxygen-rich organ that, along with stressors like UV radiation and visible light,
provides a highly oxidative microenvironment leading to cellular damage [7, 11, 12]. In order
to combat this onslaught of oxidative damage, cells require not only effective antioxidant
defense mechanisms but also cellular repair both at the organellar and macromolecular levels.
Autophagy (referring mainly to macroautophagy), along with proteasomal degradation and
DNA repair mechanisms, provides this critical housekeeping service to almost every cell type
in the eye from the cornea in the anterior part of the eye to the retina/choroid in the posterior [3].
Figure 1. (A) Basic anatomy of the eye: principal ocular tissue components are shown. (B) Diagrammatic cross section
of the retina. (C) Fundus image of a healthy adult eye (kindly provided by Dr. Yang Sun, MD, PhD, Department of
Ophthalmology, IU School of Medicine, Indianapolis) with no ocular disease history is shown. The ganglion cell axons
exit the eye at the optic disk, which is a ‘blind spot’ due to the complete absence of photoreceptors. The macula is tight-
ly packed with photoreceptors and is critical for central vision. The fovea is a small pit-like area within the macula
highly enriched with cone photoreceptors.
Perhaps, the most convincing evidence of the importance of autophagic activity in the eye is
the preferential expression of autophagic proteins in the ocular cells and diurnal variation in
expression of autophagic protein expression in the retina [13, 14]. As early as 1977, Reme et al.
showed increased autophagosome formation in the inner segments of the photoreceptor cells
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3 hours after maximum photoreceptor disk shedding in the rat retina [15, 16]. Diurnal variation
in autophagosome formation rates was shown to be strongly dependent on light and ampli-
tudes were severely dampened in animals kept under constant darkness [17, 18]. Recent
reports have shown autophagic activity in the retinal pigmented epithelium (RPE) to be
strongly correlated to the phagocytosis of photoreceptor outer segments (POS) underlining
the importance of autophagy not just in being a housekeeping process but as an essential
component of RPE function [19, 20].
Because of its dual role in cell survival and death, autophagy has often been referred to as a
‘double-edged sword’ [21, 22]. As a degradative and recycling pathway, autophagy is essential
for sequestration and digestion of toxic waste that could otherwise lead to loss of cell function
and eventually lead to cell death. Autophagy (specifically macroautophagy) remains the only
known process by which damaged cellular organelles as large as the mitochondria can be
digested and recycled [23]. Metabolites generated from autophagic digestion and recycling
serve as essential components for new macromolecules and organelles. Because of the ability
of this process to be upregulated when the cell is subjected to stress such as nutrient starvation,
oxidative stress, hypoxia, and growth factor depletion, autophagy can be thought of as an
adaptive process that can meet the energy demand under unfavorable conditions [24].
Due to the generally non-dividing nature of many of the constituent cells of the eye, most
reports on autophagy in the eye have concluded it to be a necessary cytoprotective mechanism
that prevents the accumulation of cellular damage and inflammation over the lifetime of an
individual [25, 26]. However, reduced autophagic efficiency is implicated in a number of ocular
pathologies such as age-related macular degeneration (AMD), glaucoma, diabetic retinopathy
(DR), photoreceptor degeneration, and ocular infections. Because of its ‘destructive self-eating’
nature, when autophagic activity exceeds a certain threshold or duration, it may actually
promote cellular demise. Moreover, autophagy can ‘cross talk’ with other cell death modalities
like apoptosis to influence overall cell fate [26]. It is thus critical to understand the mechanism
and functional role of autophagy in specific cells of the eye before autophagic modulation be
incorporated in ocular therapeutic strategies.
In this chapter, we summarize the overall understanding of the role of autophagy in develop-
ment and normal aging of the eye. We then describe the aspects of autophagy with respect to
ocular diseases.
2. Autophagy in the healthy and aging eye
There is increasing evidence that autophagy plays a critical role in ocular development and
homeostasis. Developmentally, the vertebrate eye derives from coordinated interactions
between neuroepithelium, surface ectoderm, and extraocular mesenchyme (originating from
neural crest and mesoderm) [27]. The major development of the eye occurs between the 3rd
and 10th weeks of fetal development with the initial formation of the optic vesicles followed
by the gradual formation of the lens and the optic nerve [27–30]. Development of the lens
requires maturation of lens fibers by degrading the mitochondria, nuclei, Golgi apparatus, and
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endoplasmic reticulum to create the transparent organelle-free zone to allow passage of light
into the ocular chamber (reviewed in [31]). During development, the hyaloid artery supplies
the lens with much needed nutrition and eventually its distal end degrades in the inner vitreous
of the eye bulb, while the proximal end becomes the central retinal artery [32]. While the
pigmented layer and the retina form from the outer and inner layers of the posterior (4/5th)
optic cup, respectively, iris and the ciliary body are formed from the anterior (1/5th) region.
The sclera and choroid are formed from the mesenchyme on the outer side of the optic cup.
The primary and secondary lens fibers form the lens. The vitreous humor is a gel-like substance
formed from the mesenchymal cells of the neural crest (reviewed in [33]). In the normal human
eye, the photoreceptors continue to mature after birth. Foveal cone photoreceptor cell size
shrinks (from 7.5 to 2 μm diameter), while cell density increases (18–42/100 μm) until 3 years
of age [34, 35].
Programmed cell death plays a crucial role in neuroretinal development [36]. Autophagic
proteins AMBRA1 and Beclin1 are strongly expressed in chicken embryonic (E5) neural retina
[37]. Autophagy supplies ATP to energize the externalization of phosphatidyl serine on the
dying cell surface, an essential step in the clearance of cell corpses from the developing retinal
neuroepithelium. Pharmacological inhibition (3-Methyladenine) of autophagy increases
TUNEL-positive apoptotic cells [38]. It will be interesting to investigate the role of autophagy
in the development of mammalian neuroretinal cells. Autophagy has also been shown to
reduce cell size in other cell types [39–41]. Antagonistic mTOR and autophagic pathways
control activity of YAP/TAZ transcription factors, thereby influencing cell size and prolifera-
tion [42]. Differential cellular signaling to modulate autophagy and mTOR in both dividing
and differentiated photoreceptors during pre- and postnatal cone photoreceptor enrichment
in the macular fovea is an area hitherto unexplored.
Autophagic vacuoles engulfing mitochondria were reported in the lens in 1984 [43, 44].
Autophagy was the expected pathway of choice for the developing lens’ fiber cells to degrade
cell organelles to create the organelle-free zone (reviewed in [45]). Autophagosomes were
reported in both differentiating primary and secondary lens fiber cells [43, 46]. However,
during the embryonic period, deletion of either Atg5 or Pik3c3 genes in mice did not affect
lens organelle clearance [43, 46]. Costello et al. put forward an alternative hypothesis that since
both Atg5- and Pik3c3-independent autophagy have been reported and that mutation in
autophagy gene FYCO1 causes autosomal recessive congenital cataract, the role of autophagy
(and mitophagy) cannot be ruled out in organelle clearance [47–50]. ATG5-independent non-
canonical autophagy has also been implicated in the mitochondrial clearance required during
metabolic reprogramming of induced pluripotent cells (iPSC) [51]. Perhaps a simpler ap-
proach, where overall lens autophagic flux is inhibited (possibly by inhibiting lysosomal
fusion), needs to be adopted to confirm that organelle clearance in developing lens is not
dependent on autophagy. Furthermore, it remains to be seen if the various proteolytic
mechanisms active during lens fiber differentiation can compensate autophagic deficiency (for
further reading, please refer [30]).
The adult eye is enclosed in the outer fibrous tunic, composed of the sclera (posterior 5/6th of
the eye bulb) and cornea (transparent anterior part) (Figure 1A). The middle layer is known
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as the vascular tunic (or uvea) comprising of the choroid, ciliary body, and iris. The ciliary body
supports the lens and controls the shape of the lens with the ciliary muscle. The innermost
layer is the retina with ten distinct layers. Moving in a direction from the inside of the eye,
these layers are arranged as (1) the inner limiting membrane; (2) the nerve fiber layer; (3) the
ganglion cell layer; (4) the inner plexiform layer; (5) the inner nuclear layer; (6) the outer
plexiform layer; (7) the outer nuclear layer; (8) the outer limiting membrane; (9) the photore-
ceptor (rods and cones) layer; and (10) the retinal pigmented epithelium (RPE) (Figure 1B) [52].
The innermost layers of the neural retina comprise of different classes of neuronal cells such
as the ganglion cells, the Müller, horizontal, bipolar, amacrine cells, and the photoreceptor cells
(rods and cones). Together, these cells constitute a complex network of visual sensory synapses
that communicate the visual signals to the brain via the central nervous system.
The extraocular muscles (EOMs) control eye directional movement and eyelid movements and
contain cells that are likely to accumulate mitochondrial damage during aging, resulting in
slower eye muscle movements [53–55]. McMullen et al. reported that autophagy was severely
impaired in 18- and 30-month-old compared with 6-month old Fisher 344-Brown Norway rat
EOMs supported by their observation of decline in LC3, ATG5, and ATG7 [56].
The cornea, being a non-keratinized epithelial surface, requires to be kept moist by tear
secretions from the lacrimal, meibomian (or tarsal) glands, and the conjunctival goblet cells
[57, 58]. Basal autophagy-lysosomal activity in the constituent fibroblasts (also known as
keratocytes) of the corneal stroma is critical for the clearance of transforming growth factor
β-induced protein (TGF-βIp) (discussed in detail in next section along with other corneal
abnormalities) [59].
The lacrimal glands produce the aqueous components of the tears (i.e., lacritin, lysozymes,
lactoferrin, lipocalin, secretory immunoglobulin A (IgA) and complements), which protect the
cornea against a large number of infectious agents (reviewed in [60]). The meibomian glands
produce the lipid components of tears called meibum consisting of a variety of esters and fatty
acids that prevent evaporation of the tears from the conjunctiva (reviewed in [58]). The mucous
secretion from the conjunctival goblet cells allows for even distribution of the tears over the
conjunctival surface (reviewed in [61]).
Earliest data on autophagic activity in the acinar cells of the lacrimal glands showed dramatic
buildup of autophagosomes upon treatment with vinblastine (microtubule inhibitor that
blocks autophagosome–lysosome fusion), strongly suggesting the existence of basal autoph-
agy [62, 63]. Autophagy (along with apoptosis) is upregulated in response to inflammation
induced in BALB/c mice lacrimal glands, resulting in acinar cell death. It remains to be
investigated whether this phenomenon is critical for tissue repair and remodeling post-
inflammation injury [64]. The tear component glycoprotein, lacritin, has been reported to
protect in vitro-cultured corneal epithelial cells under inflammatory cytokine-induced stress
via upregulation of autophagic flux [65–67]. Lacritin-stimulated acetylation of transcription
factor FOXO3a, followed by acetylated FOXO3a-ATG101 coupling and coupling of stress-
acetylated FOXO1 with ATG7, is critical for this autophagic response [68].
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The earliest publication on autophagy in the conjunctiva described autophagic structures in
guinea pigs [69].
The trabecular meshwork (TM) is located in the iridocorneal junction of the eye and is
responsible for draining the aqueous humor from the eye via the anterior chamber (Fig‐
ure 1B) [70]. Porcine TM cells under hypoxic conditions show increased autophagy, perhaps
as a response to increase reactive oxygen species (ROS) [71]. TM cells when chronically exposed
to oxidative stress tend to develop lysosomal basification and membrane permeabilization
owing to the increased lysosomal iron content. Although autophagic activity is elevated in
oxidatively stressed TM cells, the levels of ATG5, ATG7, and ATG12 are significantly reduced
[72, 73]. This paradoxical observation hints at the possibility of the existence of active and
potentially novel non-canonical autophagic pathways that may use another enzymatic
network to modify LC3. Ex vivo human trabecular meshwork, cells collected from healthy
donor eyes, displays an increase in both oxidative DNA damage (8-hydroxy-2-deoxyguano-
sine) and autophagic activity markers (increased LC3II/I ratio and reduced p62/SQSTM1) in
older donors [74]. However, in vitro data have failed to establish autophagy as either an inducer
of senescence or an inhibitor. Trehalose-induced autophagy and oxidative stress-induced
senescence-associated-β-galactosidase (SA-β-gal) activity, while rapamycin treatment did not
show the same effect [73].
The iris modulates the amount of light entering the retina by controlling the size and diameter
of the pupil. The iris contains pigmented epithelial cells that have the same origin as RPE and
contain melanosomes [75]. In vitro-cultured newt iris epithelial cells dedifferentiated to lens
cells and this process was accompanied by the sequestration of the melanosomes, ribosomes,
and multivesicular bodies (MVB) in autophagic vesicles [76]. Autophagy has not been widely
studied in the iris. However, since the iris-pigmented epithelial cells and RPE have some
common features like melanosome content as well as phagocytic ability, it is expected that they
would have high metabolic rates making them susceptible to accumulating cellular damage
[77, 78]. Therefore, autophagy, among other housekeeping processes, must be at an efficient
level in order to exacerbate this cellular damage. Consistent with this hypothesis, Petrovski et
al. have reported an increase in basal LC3 levels in iris sections from aging human cadaver
eyes [79]. Interestingly, the authors observed LC3 expression in mouse iris sections. They also
reported an increase in basal LC3 levels in the non-pigmented aqueous humor producing
epithelium of the ciliary body (connection between iris and choroid) of aging human cadaver
eyes and hypothesized that autophagy might play a key role in the maintenance of intraocular
pressure (IOP) in the aging eye. Similar LC3 expression was observed in mouse ciliary body
[79]. One must however exercise caution before interpreting autophagic protein expression in
any ocular tissue. We and others have observed significant oscillations of autophagic protein
expression in the retinal layers of rodents [19]. Recent reports show oscillatory expression of
circadian clock genes Bmal1, Clock, Cry1, Cry2, Per1, and Per2 in the irisciliary body of C57BL/
6 mice with significant correlation with diurnal IOP variations over a 12-h/12-h light/dark cycle
[80]. Per1-deficient mice show increased susceptibility to neuronal injury after cerebral
ischemia and one of the key reasons behind this has been hypothesized to be a dramatic
attenuation of autophagic activity [81]. Therefore, before conclusions are made about the
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absence of expression of autophagic proteins in the iris of mice, diurnal/circadian studies on
autophagic protein expression must be conducted.
During normal aging, basal LC3 levels are elevated in the lens of human cadaver eyes [79].
Analysis of autophagic gene expression by a combined approach of microarray, qRT-PCR, and
Western blotting revealed as many as 42 autophagy-related genes in microdissected human
lens epithelium and fiber cells (age range: 47–69 years) providing convincing evidence of
autophagy in the lens [82, 83]. Two independent reports suggest the critical role of autophagy
in maintaining lens homeostasis in mutant models of αβ-crystallin (R120G) and αA-crystallin
(R120A) (discussed in detail in the next section) [84, 85].
The mean retinal thickness of the human eye reduces by about 0.53 μm annually with con-
current loss of macular thickness, implying that there is a significant cell loss in the retina even
with no pathology [86, 87]. It remains a challenge to researchers to determine whether changes
in cell biology of the retinal cells that trigger onset of disease are different from the normal
aging process. The nerve fiber layer shows substantial thinning over time (nearly 150/mm2
during an average lifetime) due to the significant loss of retinal ganglion cells (RGCs) that make
up the ganglion cell layer of the retina and convey visual signals from the photoreceptor layer
to the optic nerve that constitutes of RGC axons and glial cells [88–91]. The optic nerve also
suffers some detrimental changes during aging due to the loss of ganglial axons [92]. The
neuroretinal rim area reduces at a rate of 0.28–0.39% annually, while the optic cup area and
the vertical cup diameter start to increase especially after the third decade of life [93]. Apoptosis
is considered the primary cell death mode for RGC loss [94–96]. Reports suggest that autoph-
agy may promote RGC survival after optic nerve axotomy in mice [97]. Atg5, 7 and 12, LC3,
and Beclin-1 expression is elevated in the mouse RGCs up to 7 days after optic nerve injury
[98]. It has been suggested that autophagic flux impairment in the RGC axons may lead to age-
associated changes in the optic nerve [99]. We will elaborate the role of autophagy in terms of
RGC and disease in Section 3.
Photoreceptor density decreases at a rate of 0.2–0.4% annually with a greater degree of rod cell
loss than cones causing reduced dark adaptation in aged individuals [100, 101]. This loss is
mostly in the peripheral and the parafoveal retina rather than at the fovea (Figure 1C) [102].
We have previously shown strong expression of Atg9 and LC3 in the ganglion cell layer, retinal
vessels, a subpopulation of the inner nuclear layer, the outer nuclear layer of rods and cones,
and the RPE [103]. Deletion of Beclin1 or Atg7 or mitophagy-specific Parkin gene in mice causes
severe retinal degeneration along with accumulation of abnormal mitochondria [104].
The RPE monolayer consists of perhaps the most multifunctional cells of the eye. The RPE has
a plethora of functions such as phagocytosis of photoreceptor outer segments, renewal of
chromophores in visual transduction cycle, supplying nutrients from the choroidal side to the
photoreceptors, ion, and metabolite exchange and light absorption (reviewed in [7]). Like the
entire retina, the RPE is also prone to age-associated decline in function and vitality and
accumulate massive cell damage even during normal aging [104, 105]. Additionally, the RPE
has to combat light and reactive oxygen species induced damage not just to its own cellular
components but also to those of the photoreceptors. Aging changes in the RPE layer is not
uniform across the retina [105, 106]. It appears that the peripheral cell area increases while that
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at the central retina declines. Cell density decreases with increasing distance from the fovea,
but the foveal RPE cell density is relatively very stable. Surprisingly, the aged non-diseased
macula shows a population of apoptotic RPE [107]. Both the RPE and photoreceptors are highly
metabolic and a healthy pool of mitochondria is required to meet this energy demand. There
is a significant reduction in the number of healthy mitochondria and extensive damages to
mitochondrial cristae, and matrices are observed [108]. A number of publications together have
shown RPE and photoreceptors expressing autophagy proteins (p62, LC3, ATG7, ATG9, and
Beclin1) in both human cadaver and rodent model retina sections [13, 14, 19, 103, 109].
Furthermore, as mentioned earlier, diurnal oscillations of autophagic proteins and autopha-
gosomes in the RPE/photoreceptor layers confirm a functional role of autophagy that is
integrally linked to POS phagocytosis [19, 110, 111]. Autophagic digestion of rhodopsin light
pigment in rod photoreceptors is also necessary for adaptation to changes in light intensity (3–
200-lx) [110]. Lentiviral shRNA-mediated silencing of autophagic genes (Beclin1 and ATG7)
or 3-Methyadenine (3-MA)-mediated autophagy inhibition in human RPE in cell culture
increases susceptibility to oxidative stress with compromised mitochondria, increased
lipofuscin, and reduced cell viability [13]. Deletion of RB1CC1 in rodent RPE caused severe
retinal degeneration underlining the importance of basal autophagy in the RPE [109]. Levels
of autophagic protein such as ATG7, ATG9, and LC3 increase with aging in the retinal layers
including RPE and photoreceptors in both human cadaver donor and c57Bl/6 mouse retina
sections [13].
Non-canonical LC3-associated phagocytosis (LAP), dependent on Atg5 and Beclin1 but
independent of the autophagy pre-initiation complex consisting of Ulk1/Atg13/Fip200, was
reported to be critical for degradation of POS and renewal of retinoids required for chromo-
phore synthesis for optimal visual function (Figure 2) [111, 112]. Melanoregulin, a 28 KDa
membrane-associated protein is critical for lysosomal hydrolase activity in the RPE as well as
for RILP-p150Glued complex-mediated retrograde melanosome transport via actin filaments
in melanocytes [113, 114]. Frost et al. demonstrated a diurnal variation in melanoregulin
expression in the RPE and its distinct association with the ATG5-dependent LAP [111]. Loss
of melanoregulin causes accumulation of phagosomes and lipofuscin in the RPE with elevated
cathepsin-D secretion that could injure not only the RPE but also the adjacent ocular layers
[111, 114]. Furthermore, ROS generated from NADPH oxidase activity resulting from the
delayed clearance of all-trans retinal (activated visual chromophore of the visual transduction
cycle) shows severe RPE cytotoxicity [104]. LC3 association with phagosomes is signaled by
elevated NAPDH oxidase activity in other ‘professionally’ phagocytic cells like macrophages
[115]. Park2 (mitophagy receptor protein) and LC3 activity are indispensable for RPE defense
against all-trans retinal induced cytotoxicity [104]. It is now evident that while basal rate
canonical autophagy is critical for quality control and stress adaptation, non-canonical forms
of autophagy where some but not all components and mechanisms of the canonical form
participate, supports the very core of retinal visual function.
The ocular vasculature has several indispensable functions including supply of oxygen and
nutrients to the ocular components; transportation of ions and metabolites; circulation of
immune-surveillant cells; and exclusion of pro-inflammatory cytokines and molecular toxins
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[116]. The study of autophagic flux and its role in ocular vascular endothelial physiology is
still at rudimentary stages. However, recently it has been reported that conditional deletion of
endothelial Atg7 in ApoE−/− mice results in accumulation of oxidized LDL within the RPE and
choroidal vascular endothelium of the eye underscoring the importance of autophagy in
vascular lipid homeostasis [117]. Conflicting opinions exist regarding the role of autophagy in
angiogenesis most likely due to the different tissue source of the endothelial cells under study.
Lee et al. have recently reported that Beclin1 deficiency leads to increased hypoxia-induced
angiogenesis in human pulmonary artery endothelial cells [118]. On the other hand, in bovine
aortic endothelial cells, Du et al. suggest that autophagy promotes angiogenesis and elevated
ROS levels [119]. Autocrine vascular endothelial growth factor (VEGF) suppresses autophagy
in human umbilical vascular endothelial cells (HUVECs) to maintain cell viability. The role of
αvβ3 and αvβ5 integrins has long been implicated in retinal neovascularization [120, 121].
αvβ5 integrins act downstream of VEGF activating focal adhesion kinases (FAKs) that are
critical for cell migration [122]. Recent reports suggest a critical role of autophagy in restricting
integrin activity and thus inhibiting cell migration [123]. Autophagy receptor NBR1 has been
shown to be a specific cargo receptor for targeting focal adhesion components to the lysosome
for degradation [124].
Figure 2. Classic and non-canonical LC3-associated phagocytosis (LAP) in the RPE: basal autophagy is essential in the
RPE to maintain organelle and protein quality. Phagocytosis of ingested outer segments may be mediated by autopha-
gy components LC3, ATG5-12-16 complex, and delivery of the phagosome to the lysosome is dependent on these pro-
teins underlining the existence of a non-canonical autophagic pathway in the eye that supports RPE phagocytic
function. Furthermore, melanoregulin (MREG) facilitates LC3 recruitment to the phagosomes. Phagocytosis is essential
for renewal of all-trans retinol to 11-cis retinal visually active chromophore that is sent to the photoreceptors for ena-
bling the visual cycle. Hence, while basal canonical autophagy is essential for basic housekeeping of the RPE, non-can-
onical autophagy supports at least in part the visual cycle and photoreceptor disk processing.
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These mechanisms need to be reinvestigated in retinal endothelial cells in order to elucidate
the role of autophagy in maintenance of retinal vasculature. Inhibiting autophagy in the RPE
in vitro elevates the levels of pro-angiogenic intercellular adhesion molecule (ICAM), stromal
cell-derived factor (SDF-1) and VEGF A in response to challenge by lipofuscin component
A2E [125]. Therefore, retinal vascular stability may not only be influenced by autophagy in the
vascular endothelial cells but also by the cross talk from adjacent cell layers.
One of the inevitable consequences of oxidative damage in the aging retina is the accompa-
nying inflammatory response and elevated levels of damage-associated molecular patterns
(DAMP) [126]. Although the eye was considered immune privileged for a long time, immu-
nocompetent cells like the monocyte-derived cells, microglia, dendritic cells, and perivascular
macrophages have been detected in the retina [127–130]. Ample evidence suggests that the
inflammation observed during normal tissue aging is an adaptive response and the word
coined for this inflammation is ‘para-inflammation’ [129, 131–133]. Para-inflammation is
required for retinal tissue homeostasis plays a crucial role in tissue repair/remodeling, but
when para-inflammation becomes chronic or progresses to destructive inflammation, retinal
damage and pathology may ensue (reviewed in [134]). As mentioned earlier, the aging retina
shows an increase in apoptotic cells. However, several reports have recently indicated that
other cell death modalities like autophagy and necrosis may also exist in the eye that may
become particularly active in retinal degenerative conditions [135, 136]. While apoptosis
restricts the release of inflammatory danger signals, late-stage apoptosis and necrosis can
initiate DAMP-mediated inflammation. Autophagy, at least in the early stages, has been
considered a protective response that suppresses inflammatory signals [137]. Shi et al. showed
the activation of autophagy by sterile inflammation (NLRP3- and AIM2-mediated inflamma-
tion) limited caspase-1-mediated maturation of IL-1β and IL-18 [138]. Impairing autophagy in
RPE leads to not only inflammasome activation but also macrophage-mediated angiogenesis
[139–141]. The age pigment, lipofuscin, is a common feature of many post-mitotic cells
throughout the body and is largely derived from autophagic removal of damaged organelles
[142]. Lipofuscin accumulation occurs in an age-dependent manner in both photoreceptor cells
and the RPE. In both cell types, lipofuscin is derived at least in part via autophagy of damaged
organelles (e.g., mitochondria) [142], but the situation is more complicated in the RPE where
(a) lipofuscin is also an inevitable consequence of phagocytosis of spent photoreceptor outer
segments [143] and (b) phagocytosis is linked to a non-canonical autophagy pathway [111,
112]. Lipofuscin is both a cause and consequence of oxidative stress and oxidative stress-
mediated accumulation of lipofuscin increases dramatically in the RPE when autophagy is
pharmacologically inhibited [13].
Considerable cross talk exists between apoptosis and autophagy. p53 and Bc1-2 family proteins
and calpain have been classically considered as apoptotic proteins but can also modulate
autophagy [144–146]. For example, Beclin1 is cleaved by caspase upon depletion of IL-3 in Ba/
F3 cells leading to inactivation of autophagy and release of proapoptotic cytochrome c from
the mitochondria [147]. Direct cleavage of ATG3 (a ubiquitin-like-conjugating enzyme
involved in autophagosome biogenesis) by activated caspase-8 can lead to inhibition of
autophagy and cell death [148]. Yet other reports show autophagy prevents necrosis by
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reducing metabolic stress [149]. Although cross talk between cell death pathways needs to be
confirmed in ocular cells, it is safe to assume that autophagy in the aging eye plays a critical
role in maintaining balance between the cell death modalities to avoid a pathological scenario.
Arrested autophagic flux by lysosomal disruption enhances buildup of ubiquitinated protein
aggregates and cell death under oxidative stress that cannot be prevented by apoptotic caspase
inhibitor (zVAD-FMK) [150].
3. Autophagy in ocular disease
3.1. Autophagy in congenital ocular abnormalities
Several congenital deformities of the eye occur such as coloboma, congenital glaucoma,
congenital cataracts, congenital detached retina, partially persistent iridopupillary membrane,
persistent hyaloid artery, microphthalmia and Peter’s anomaly, Leber’s Congenital Ameurosis
[151–156]. While the cause of most of these diseases is rooted deep in mutation of genes such
as PAX2, PAX6, CYP1B1, GLC3A, GLC3B, GLC3C, FOXC1, CEP290, CRB1, GUCY2D, RPE65,
several reports suggest autophagy may be compromised in some of these diseases [157].
Persistent hyaloid artery and persistent hyperplastic primary vitreous (PHPV) could result
from incomplete involution of the hyaloid vessel [32, 158]. Studies have shown that hypoxic
conditions, as seen in the developing eye, increase autophagic activity in vascular endothelial
cells. Hypoxia plays a major role in triggering the hyaloid vessel regression and activation of
autophagy seems to enhance hyaloid regression in the developing eye [159]. Recessive
mutations in EPG5 cause a rare inherited congenital multisystem disorder called Vici syn-
drome with defective systemic autophagy [160]. EPG5, the human homolog of the Caenorhab‐
ditis elegans autophagy gene epg-5, encodes a key protein (ectopic P-granules autophagy
protein 5) that regulates the formation of autolysosomes [160]. Retinal hypopigmentation and
bilateral cataracts are among the chief manifestations of this disorder, once again suggesting
the importance of autophagy in retinal development (reviewed in [157]). Mutations in WDR45
(also known as WIPI14) cause a rare biphasic X-chromosome-linked disorder called beta-
propeller protein-associated neurodegeneration (BPAN) [161, 162]. WDR45 interacts with
ATG2 and ATG9 that regulate lipid and membrane supplies for autophagosome formation
and elongation [163–165]. A subset of BPAN patients has optic nerve atrophy suggesting a
possibility that defective autophagy may be part of the disease etiology [166]. Congenital eye
disorders typically emerge from underlying genetic mutations, which may often prove difficult
to manage therapeutically. Understanding the effect of these genes on cell biology leading to
the disease may, in some cases, provide a better therapeutic avenue.
Autophagy is an integral part of developmental cell biology that is coordinated by a vast
network of genes [167]. Although still at rudimentary stages, research on the role and fate of
autophagy in ocular development must be intensified in the search of more promising
therapies in debilitating congenital eye disorders.




Several topical eye ointments contain benzalkonium chloride (BAC) as a preservative that has
been shown to induce caspase-independent cell death in a conjunctival cell line, was reversible
by autophagy induction [168].
3.3. Cornea
The consequences of corneal infection can be devastating with corneal scars that would require
corneal transplant [20]. Toxoplasma gondii and herpes simplex virus-1 (HSV-1) are two most
common pathogens that can directly infect the cornea. Alternately, HSV-1 can infect the cornea
indirectly via first infecting the oral mucosa [169]. In some extremely infectious cases, HSV-1
infections may cause stromal keratitis leading to blindness and is the leading cause of corneal
blindness globally [170]. A key virulence mechanism of HSV-1 is to hijack and inhibit autoph-
agy in the host cell via the binding of Beclin1 with the viral protein ICP34.5 [171, 172]. Addi-
tionally, IPC34.5 can inhibit autophagy induction by inhibiting the antiviral eIF2alpha kinase-
signaling pathway (including PKR and eIF2alpha) [173]. Contradicting opinions exist as to
whether autophagy promotes HSV-1 infection or inhibits it. Petrovski et al. recently showed
that autophagy was induced in HSV-1-infected rabbit corneal cell survival against apoptosis
[174]. Yakoub et al. showed that HSV-1 does not increase autophagic activity in the cell but
basal autophagy is required for it to infect the host cells [175] and pharmacological induction
of autophagy in host cells suppresses HSV-1 infection [176]. Yet in another independent study,
Alexander et al. reported no effect on HSV-1 replication in autophagy-deficient host mouse
fibroblast cells [177]. It seems that the experimental model of choice from one research team
to another may affect the final outcome of autophagy on HSV-1 in the infected host cell.
T. gondii infection in the cornea is a classic example where an invading pathogen disrupts
cellular endosomal-lysosomal fusion and therefore prevents itself from degradation by
lysosomal enzymes [178]. Defects in the CD40 pathway that activates macrophages to eliminate
T. gondii cause ocular toxoplasmosis, suggesting autophagy may prevent T. gondii-mediated
infection [179, 180].
Granular Corneal Dystrophy 2 (GCD2), an autosomal dominant disorder caused by mutation
R124H in the transforming growth factor β-induced gene (TGFBI) on chromosome 5q31, shows
dramatic accumulation of mutant transforming growth factor β-induced protein (TGF-βIp) in
autophagosomes and/or lysosomes of corneal fibroblasts [59]. Autophagy is activated, but the
rate of autophagic degradation is not sufficient to inhibit the accumulation of the aberrant
protein or polyubiquitinated proteins that are also digested in part by autophagy [59, 181].
3.4. Trabecular meshwork
Defects in fluid drainage by the TM can lead to elevated IOPs and eventually cause irreversible
damage to the optic nerve leading to glaucoma. Glaucoma is manifested with loss of peripheral
vision leading eventually to complete blindness [182–184]. Both elevated IOP and biaxial TM
stretching have been independently shown to promote autophagosome formation [185, 186].
Additionally, aging TM is subjected to both hypoxic and highly oxidative conditions that cause
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increased ROS production and accumulation of non-degradable material along with lipofuscin
in lamina cribrosa as well as TM cells [187]. In both cell types, autophagic flux is severely
impaired contributing to glaucoma pathogenesis [73, 188]. Autophagy seems to be protective
from apoptotic caspase signals in TM cells [189].
3.5. Optic nerve
Optic nerve damage is a commonality in all glaucoma subtypes [190]. Other retinal neuropa-
thies such as optic neuritis, hereditary optic atrophy, and traumatic injury may also lead to
degeneration of retinal ganglion cell axons in the optic nerve [191]. Optineurin overexpression
in retinal ganglion cells (RGC-5) in vitro was found to be beneficial via its stimulatory effect on
autophagy [192]. However, some reports contradict this hypothesis suggesting that autophagy
may, in chronic hypertensive glaucoma models, be neuropathic to the optic nerve [99, 186].
This disagreement may arise from variations in disease stage and models under investigation
(reviewed in [191]).
3.6. Lens
As mentioned in the earlier section, there still seems to be considerable debate over the role of
autophagy in digestion of organelles of differentiating lens fiber cells to create the organelle-
free zone. However, even the reports that argue against the role of autophagy in organelle
clearance suggest that it is indispensable for lens quality control. Morishita et al. showed that
Pik3kc3/VPS34 deletion in mouse caused congenital lens defects including cataract and that
in ATG5 deletion mice lens, the lens developed age-related cataracts although not congenital
cataracts [46]. Mutations in FYCO1 (facilitates microtubule-dependent directional transport of
autophagosome vesicles) show severe autosomal-recessive congenital cataracts in patients [48,
193]. αβ-Crystallin mutation (R120G) in hereditary cataract mouse model causes concurrent
increase in autophagosome fractional volumes and p62-positive aggregates in lens suggesting
impaired autophagic flux that leads to increased lens opacity [194]. Similar results were also
observed in a hereditary mutant double knock-in (R49C+/+) mouse model where autophagic
flux also seemed impaired [85]. Recently, an ESCRT-III subunit CHMP4B has been proposed
to be involved in autophagosomal clearance of extranuclear DNA and chromatin [195].
CHMP4B mutation is associated with autosomal dominant posterior polar cataract formation
[196].
3.7. Retina
Many studies have investigated the implications of autophagy in retinal degenerative diseas-
es [12–14, 103, 109, 125, 150, 194, 197, 198]. Age-related macular degeneration (AMD) is an
aging-associated neuropathy that affects primarily the photoreceptors and RPE in the macula
resulting in loss of peripheral vision and eventual legal blindness [199]. Early in AMD
pathology, sub-RPE deposits known as drusen are observed on Bruch’s membrane (BM) by
fundoscopy. There are two types of AMD: ‘dry AMD’ characterized by geographic atrophy
(GA) and ‘wet AMD’ characterized by neovascularization. Although a heterogenous disease,
the key reason behind the pathology is the increased susceptibility of the RPE to oxidative
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stress [200, 201]. Diseased retina shows a significantly greater extent of damaged organelles
(mitochondria, peroxisome, melanosomes, etc.) and protein aggregates compared to age-
matched healthy retina [108]. The overall accumulation of damaged organelles and macro-
molecules suggests a collapse of overall antioxidant and proteolytic capacity of the RPE that
sets up the stage for disease [202]. Not surprisingly, autophagy has been shown to be severely
impaired in AMD retinas of both human cadaver eyes compared with age-matched donors as
well as in AMD mouse models [13, 14, 198]. In vivo deletion of autophagic gene RB1CC1 in
mouse retina results in retinal degeneration that shares many features with AMD disease [109].
RPE cells in vitro accumulate lipofuscin and greater loss of mitochondrial activity and mem-
brane integrity under oxidative stress when autophagy is inhibited [13, 125, 203]. Autofluor-
escent lipofuscin in the RPE destabilizes the lysosome and is a hallmark of RPE senescence
that has been widely implicated in AMD [204, 205]. Lysosomal destabilization leads to a
severely impeded autophagic flux that has been recently suggested in dry AMD where a higher
accumulation of p62 was observed in the foveomacular regions of AMD patient retinas
compared with age-matched donors [14]. Interestingly, as mentioned earlier, autophagy
inhibition in lipofuscin chromophore A2E-laden RPE results in elevated levels of several pro-
inflammatory and pro-angiogenic factors that suggest a possible role of autophagy in both dry
and wet forms of AMD [125].
Diabetic retinopathy (DR) is a retinal complication characterized by pericyte loss, microvas-
cular instability, blood retinal barrier (BRB) leakage, and abnormalities in the retinal vascula-
ture [206, 207]. Since pericyte loss is a key feature of DR, the effect of autophagy was
investigated in a combination mouse model of diabetes and hypercholesterolaemia. The
authors showed that autophagy promoted pericyte survival under mild stress but under
chronic stress conditions resulted in pericyte death [208]. This may be considered as a perfect
example of the dual role of autophagy both as a protector and as a destructive pathway.
Extravascular oxidized low-density lipoprotein (LDL) has been reported to be damaging to
the BRB and to cause apoptotic pericyte loss [209]. Du et al. suggested that oxidized LDL may
cause RPE injury by excessive oxidative stress, ER stress, autophagy, and apoptosis [210]. High
glucose (30 mM) conditions in the RPE result in higher levels of p62 and LC3 accompanied by
an increase in the number of autophagosomes [211]. This increase in autophagosomes is
possibly to accommodate for the increased ROS damage sustained by the mitochondria, but
it needs to be determined whether autophagic flux is reduced as lysosomal pH is reported to
be elevated under high glucose conditions [212]. As described earlier, circadian rhythmicity
and diurnal variations in expression amplitudes of autophagic proteins is a prominent feature
of the retina. Disruption of the peripheral clock has been reported in DR pathology affecting
cellular processes such as regulation of inflammation and lipid metabolism [213–216]. Our
unpublished data show dramatic phase-shift and amplitude dampening of key autophagic
proteins in the retina of rodent models of diabetes (manuscript under preparation). It remains
to be elucidated how disruption of diurnal rhythm dysregulates the normal balance between
retinal cell metabolism and autophagy, which contributes to DR pathology.
Photoreceptor degeneration is widely observed both in AMD as well as in retinitis pigmentosa
(RP). The latter is a highly hetergenous disease with hereditary mutations in multiple gene loci
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[217]. Both caspase-dependent and caspase-independent pathways are involved in photore-
ceptor cell death in RP [218–220]. rd/rd mouse, the rds/rds mouse, and the light-damage model
in albino mice show several elements of the autophagic pathway to be upregulated. This
induction seemed secondary to an increase in oxidative stress markers, suggesting that
autophagy may be upregulated specifically to remove damaged photoreceptors [221].
Inherited lysosomal storage disease Niemann–Pick type C (NPC) disease is caused by
mutations in genes NPC 1 and 2 [222]. LC3 and autophagosmal numbers are elevated in the
ganglion cell layer of Balb/cNctr-Npc1m1N/J mouse model possibly because of disruption of
autophagic flux and reduced degradation of autophagosomes in the lysosome [223].
3.8. Retinal detachment
Retinal detachment has a number of causes and could be rhegmatogenous or may due to other
causes such as traumatic brain injury, severe myopia, retinal tear, or vascular abnormalities
frequently encountered in diabetic retina and hypertension [224–227]. In rodent models, retinal
detachment induced by subretinal injection of 1% hyaluronic acid resulted in a rapid increase
in autophagic activity 3 days after insult. However, 7 days post-injury the autophagic response
declined with a simultaneous rise in calpain activity resulting in photoreceptor cell death.
Calpain inhibition resulted in increased autophagy and prolonged the survival of photore-
ceptors [228]. Furthermore, activating autophagy in the same model in Fas-dependent manner
inhibited apoptotic death of photoreceptors [229]. Unpublished results suggest hypoxia
(increased Hif1α and Hif2α protein levels) induced by the retina-RPE separation is a key
inducer of autophagy in vivo. In an independent study, Dong et al. confirmed the increase in
autophagy 3 days after retinal detachment induction. They also showed induction of necrop-
totic cell death as seen by increased RIP kinase activation [230]. Although they concluded that
autophagic and necroptotic cell death can be blocked by the use of necrostatin, it must be
considered that all procedures were done at 3 days post-injury when autophagy is at its peak.
It would be interesting to see whether necroptosis is still active at 5 days post-injury when
autophagy has subsided.
3.9. Uvea
The uvea (consisting of the choroid and the ciliary body) may be affected in some disease
conditions such as uveitis and uveal melanoma. Autoantigen-induced experimental autoim-
mune uveitis (EAU) in Lewis rats shows an increased autophagic activity in infiltrating T
lymphocytes that was required for disease recurrence [231].
Uveal melanoma results from malignant tumors arising from melanocytes in the uvea and is
the most common intraocular cancer [232]. Mutations in GNAQ and GNA11 genes contribute
to a majority of uveal melanoma cases [233, 234]. Ambrosini et al. showed that mutant GNAQ
promoted AKT activation via phosphorylation and deletion of mutant GNAQ upregulated
AMP kinase-dependent autophagic cell death in primary choroidal uveal melanoma cell lines
[235].
Autophagy in Ocular Pathophysiology
http://dx.doi.org/10.5772/64667
301
3.10. Autophagy in ocular inflammation
Inflammation is an unavoidable phenomenon of aging. Elevated inflammation in the eye
contributes to disease pathologies including uveitis, diabetic retinopathy, or maculopathies
[236, 237]. As discussed earlier, chronic inflammation in diseased eye is destructive and
detrimental to ocular health compared with para-inflammatory immune surveillance that
responds to, and repairs, localized tissue injuries. In AMD, drusen deposits play a major role
in eliciting inflammation via both the inflammasomes and the complement pathway [238].
While mild upregulation of NLRP3 inflammasome has been shown to be protective, accumu-
lation of lipofuscin, drusen, and damaged mitochondrial DNA have all been implicated in
pathological upregulation of inflammasome activity [239]. Furthermore, complement pathway
element C5a has been shown to prime the RPE cell for upregulating NLRP3 inflammasome
activity in response to light-induced damage [240].
Ocular
tissue 
Autophagic role Disease implications References
Lens Critical for proteolytic digestion and
lens quality control. Role in lens
organelle clearance during eye
development controversial.
Disrupted autophagy due to FYCO1
mutations leads to and autosomal
recessive congenital cataract.
CHMP4B mutation leads to autosomal
dominant posterior polar cataract.
Hereditary cataract mouse models show
disruption of autophagic flux.
Costello et al. [47]
Chen et al. [48]
Wignes et al. [194]
Shiels et al. [196]
Cornea Cellular housekeeping and defense
against infectious pathogens
Insufficient autophagic degradation
leads to accumulation of TGF-βIp in
autolysosomes.
T. gondii disrupts cellular endosomal-
lysosomal fusion machinery as a part of
the infectious process.
Choi et al. [251, 252, 254]
Optic nerve Promotes cell survival in RGC post-
optic nerve axotomy.
Optineurin mediated RGC in vitro
survival dependent on autophagy
stimulation.
Alternative opinions exist of autophagy
effecting cell death in chronic
hypertensive model of glaucoma.
Some BPAN patients have optic nerve
atrophy possibly due to defective
autophagy.
Park et al, [186]
Gregory et al. [166]




hypoxia, elevated IOP and biaxial TM
stretching.
Oxidative stress increases autophagy
but ATG5, ATG7, and ATG12 reduced.
Disruption of endoplasmic reticulum
autophagy may be a key feature of
myocilin accumulation seen in a
majority of glaucoma cases.
Pulliero et al. [74]
Porter et al. [185]
McElnea et al. [187]
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Ocular
tissue 
Autophagic role Disease implications References
Autophagic markers increase during
aging in donor eyes.
Ocular
vasculature
Critical for proteolytic and lipid
homeostasis.
Potential regulator of vascular stability
by prevention of angiogenesis.
Autophagy essential for hyaloid
regression and clearance during
development.
Diabetic Retinopathy: Accumulation of
extravascular oxidized LDLs due to
disrupted autophagy leads to blood-
retina barrier damage and causes
pericyte loss.
Torisu et al. [117]
Lee et al. [118]
Kim et al. [159]
Fu et al. [208]
Wu et al. [209]
Retina Diurnal modulation of Autophagic
proteins.
Non-canonical LC3 associated
Autophagy is essential for phagocytosis
is critical for degradation of POS.
Basal autophagy indispensable for
maintenance of RPE and photoreceptor
homeostasis.
Restricts sterile inflammation in the
retina
AMD: Autophagy initiation and flux are
disrupted in human donors and mouse
models for AMD.
Diabetic Retinopathy: Disrupted
autophagy may cause pericyte loss.
Kim et al. [112]
Yao et al. [19, 109];
Mitter et al. [13]
Viiri et al. [14]
Fu et al. [208]
Liu et al. [139]
Uvea Autophagy promotes cellular survival Uveal Melanoma: Inhibition of
autophagy may be effective in Uveal
melanoma therapy
Ambrosini et al. [232]
Table 1. Description of role of autophagy along with disease implications in various ocular tissues.
Autophagy plays a critical role in controlling NLRP3 inflammasome activity in the retina.
Several in vitro experiments show dramatic upregulation of inflammasome activity in RPE and
secretion of IL-1β after autophagic flux inhibition [139–141] [203]. Wortmannin inhibits
autophagy by inhibiting class III PI3Kinase [241]. Intravitreal injection of wortmannin inhibits
autophagy in vivo in mouse retina-induced inflammasome activity and CCR2+ monocyte-
derived macrophage augmentation that promotes angiogenesis [139]. Although the role of
autophagy in activating and augmenting the retinal complement pathway needs to be deeply
investigated, evidence does exist of C3- and CD63-positive deposits on Bruch’s membrane in
aged mice possibly as a result of increased autophagy and exocytosis [197] (see Table 1).
4. Autophagy as a therapeutic target in ocular pathology
Since autophagy is a pathway with a dual role in cell maintenance as well as cell death; multiple
stages such as initiation, maturation, and lysosomal fusion; and cross talk with multiple
cellular pathways, its manipulation is a challenging therapeutic option in diseases. Neverthe-
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less, autophagy has received special attention in cancer, metabolic, neurodegenerative, and
infectious diseases [242–245]. Since overall proteolytic capacity is attenuated in a majority of
ocular diseases, autophagy modulation must be incorporated in current therapeutic regimens
to achieve a better outcome.
Treatment strategies for immature cataracts have been sought after for more than a century
[245, 246]. Topical solutions with antioxidants glutathione, cysteine ascorbate, l-taurine,
riboflavin, and 2% N-acetyl carnosine showed some promise in reducing immature cataracts
[247]. Including autophagy stimulation may improve this treatment strategy. Posterior capsule
opacification, a common post-surgical complication of mature cataracts, results from the
remnant lens fibers and epithelial cells that proliferate and damage the new lens implant [248].
Laser capsulotomy surgery although usually successful may in rare occasions give rise to
retinal detachment and is also extremely challenging to execute when treating congenital
cataracts in younger patients [249]. It is not known whether autophagy (as well as other
mechanisms) supports cell survival of the remnant lens epithelial cells. Pharmacologically
stimulating cell death may involve autophagy that either promotes or inhibits survival of these
cells.
As mentioned earlier, removal of TGF-βIp deposits is a focus in granular corneal dystrophy 2
(GCD2) research. Lithium, which has shown some success in removing these deposits from
in vitro-cultured corneal fibroblasts from GCD2 patients, has also been shown to induce
autophagy as a part of its cytoprotective mechanism [250, 251]. Since TGF-βIp accumulates in
autolysosomes, autophagy stimulation by lithium or by rapamycin and melatonin as suggest-
ed in another study must be explored as a treatment strategy in this disease (please refer to
Choi et al. for more details) [59, 252–254].
Non-infectious uveitis treatment with subconjunctival injections of rapamycin as an immu-
nosuppressive agent has shown promise in clinical studies with patients showing improved
visual acuity and reduced vitreous haze with no noticeable adverse effects [255]. Mechanistic
studies may reveal that at least a part of this immune suppressive ability of rapamycin may
be credited to autophagy stimulation.
Antitumor activity is seen in combinatorial therapy involving mTOR inhibition and autophagy
inhibition with hydroxychloroquine has been shown to restrict melanoma and these treat-
ments are currently under phase-1 trial [256, 257]. Such treatment strategies may be adopted
in treatment of uveal melanoma although the fact that chloroquine may induce cataract
formation, demands that careful dose-response studies be conducted to ensure no adverse
effects [258, 259].
Autophagic degradation is attenuated in AMD. Lipofuscin accumulation in the disease has
been shown to perturb the lysosomes that have serious implications on RPE health [142, 260–
262]. Lysosomal activity disruption affects both autophagic flux and phagocytosis [263]. Hence,
putative therapies should first focus on restoring lysosomal activity to improve degradation
of existing autophagosomes. Rapamycin administration to senescence-accelerated OXYS rats
improved the RPE morphology in the retina [264]. Clinical trials using rapamycin to treat GA
in advanced stages of dry AMD showed ‘no positive anatomic or functional effects’ [265]. The
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treatment failure may partly be attributed partly to the fact that the intervention may have
been attempted at a time when the disease was well underway with well-developed AMD
lesions. An earlier intervention in addition to stimulating lysosomal activity may produce
better results.
To include autophagy in ocular therapeutic strategy for better treatment outcomes, the
following aspects must be considered. (1) Stimulating autophagy initiation: Several pharma-
cological activators of autophagy have been identified for possible therapeutic treatments.
Rapamycin and its analogs (CCI-779, RAD001 and AP23573) act via inhibiting the mTOR
pathway. Metformin mediates AMP kinase activity which stimulates autophagy initiation. Yet
other drugs such as lithium and valproic acid have been identified that stimulate autophagy
induction. Studies using rapamycin or resveratrol have shown promising results in treatment
of cardiac hypertrophy [266, 267]. Clearance of α-synuclein and polyQ mutant Huntingtin
aggregates has also resulted from using rapamycin in Parkison’s and Huntingtin disease,
respectively [268–270]. Also, small molecule enhancers of rapamycin have also been reported
that show positive results in neuroprotection. However, whether stimulation of autophagy
would be at all beneficial in retinal diseases perspective depends significantly on the status of
lysosomal machinery at the stage of the disease when intervention is attempted. Stimulating
autophagosome biogenesis when lysosomes are destabilized will not alleviate the cytotoxic
burden resulting from damaged protein aggregates. (2) Stimulating lysosomal activity: An
effective strategy to clear aggregate proteins may be attempted by improving lysosomal
activity and thereby increasing (or restoring) the autophagic flux. Transcription Factor EB
(TFEB) is considered a ‘master regulator of autophagy’ and drives the expression of several
autophagy and lysosomal genes including p62, Atg9b, LC3B, Wipi1, and Lamp1 [271]. Gene
therapy with TFEB in mouse model of hepatic disease improved clearance of protein aggre-
gation and rescued alpha-1-anti-trypsin deficiency [272]. High efficiency gene transfers have
been achieved to specific retinal layers previously with different adeno-associated virus (AAV)
serotypes. TFEB gene transfer may dramatically improve lysosomal biogenesis and overall
autophagic flux in the RPE and may be of particular importance in AMD therapeutic strategies.
5. Summary and future directions
The autophagic machinery consists of a fine-tuned complex network of genes whose mysteries
are still being unraveled by researchers. Autophagy research in the eye so far has established
it as an essential housekeeping pathway indispensable for ocular homeostasis. While thera-
peutic strategies to regulate autophagy in ocular diseases are still in rudimentary stages,
promising results from initial trials have raised hope of autophagic modulation moving
gradually from bench to clinic. The challenge lies in modulation of autophagy to the levels
required in the particular disease scenario, that is do we want cell death in malignant conditions
or just to restore autophagy to levels where it can not only clear cellular waste but also
effectively reverse inflammation and contain cell death signals.
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